Steinweiler, Germany

Michael Linnebacher

This inventor holds 4 USPTO granted patents and 3 published patent applications. Top assignees: Mtm Laboratories, Ag, Roche Mtm Laboratories Ag, Other. Active years: 2009-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michael Linnebacher. Retrieved from https://idiyas.com/inventor/michael-linnebacher

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 4 

% Patents Active = 75.0

Average Co-Inventor Count = 4.2

ph-index = 2

Forward Citations = 33(Granted Patents)


Company Filing History:


Years Active: 2009-2015

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Biography of Inventor Michael Linnebacher

Introduction: Michael Linnebacher is a notable inventor based in Stennweiler, DE. He has made significant contributions to the field of cancer research and immunotherapy, holding a total of 4 patents.

Latest Patents: His latest patents include "Immunization of an individual against carcinomas and the preliminary stages thereof," which relates to a pharmaceutical composition for immunization against carcinomas. Another significant patent is "Compounds and methods useful for detection and treatment of cancer," focusing on methods applicable in cancers associated with frameshift mutations.

Career Highlights: Throughout his career, Linnebacher has worked with various companies, including Mtm Laboratories. His work has been pivotal in developing innovative approaches to cancer detection and treatment.

Collaborations: Linnebacher has collaborated with esteemed colleagues such as Magnus Von Knebel-Doeberitz and Johannes Gebert. These collaborations have furthered his research and contributions to the scientific community.

Conclusion: Michael Linnebacher's work exemplifies the impact of innovation in the medical field, particularly in cancer research. His patents and collaborations highlight his commitment to advancing healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…